细胞淋巴瘤-话题@MedSci

#细胞淋巴瘤#

385篇内容 | 5340人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1702615, encodeId=1a1e1e0261500, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Autolus Therapeutics公布其CD19/CD22双靶CAR-T细胞疗法在大B细胞淋巴瘤中的阳性临床数据, objectType=article, longId=187159, objectId=649918e159e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=649918e159e2, replyNumber=0, likeNumber=64, createdTime=2020-02-10, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=649918e159e2, moduleTitle=Autolus Therapeutics公布其CD19/CD22双靶CAR-T细胞疗法在大B细胞淋巴瘤中的阳性临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=649918e159e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702577, encodeId=bf071e02577ff, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Lancet：IPH4102治疗晚期T细胞淋巴瘤的I期临床试验结果, objectType=article, longId=174329, objectId=68c11e432912, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68c11e432912, replyNumber=0, likeNumber=50, createdTime=2019-06-29, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68c11e432912, moduleTitle=Lancet：IPH4102治疗晚期T细胞淋巴瘤的I期临床试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68c11e432912)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702611, encodeId=55101e02611e5, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=林桐榆教授：复发难治弥漫大B细胞淋巴瘤治疗关键与挑战, objectType=article, longId=186206, objectId=9fb1186206ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fb1186206ed, replyNumber=0, likeNumber=93, createdTime=2020-02-25, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fb1186206ed, moduleTitle=林桐榆教授：复发难治弥漫大B细胞淋巴瘤治疗关键与挑战, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fb1186206ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702629, encodeId=4e621e026290d, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=JCO：CAR-T用于复发或难治性大B细胞淋巴瘤真实世界数据发布，结果与试验结果一致, objectType=article, longId=194692, objectId=93bf194692fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93bf194692fc, replyNumber=0, likeNumber=83, createdTime=2020-11-14, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93bf194692fc, moduleTitle=JCO：CAR-T用于复发或难治性大B细胞淋巴瘤真实世界数据发布，结果与试验结果一致, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93bf194692fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702595, encodeId=e9d11e0259578, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Verastem的PI3K抑制剂COPIKTRA治疗T细胞淋巴瘤，获得FDA的孤儿药称号, objectType=article, longId=180514, objectId=7f23180514e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f23180514e5, replyNumber=0, likeNumber=65, createdTime=2020-05-03, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f23180514e5, moduleTitle=Verastem的PI3K抑制剂COPIKTRA治疗T细胞淋巴瘤，获得FDA的孤儿药称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f23180514e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702625, encodeId=11151e0262545, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=亚盛药业的Bcl-2抑制剂APG-2575用于慢性淋巴细胞白血病或小淋巴细胞淋巴瘤的Ib/II期临床，获得NMPA的批准, objectType=article, longId=191730, objectId=1f9c191e301a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f9c191e301a, replyNumber=0, likeNumber=79, createdTime=2020-04-29, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f9c191e301a, moduleTitle=亚盛药业的Bcl-2抑制剂APG-2575用于慢性淋巴细胞白血病或小淋巴细胞淋巴瘤的Ib/II期临床，获得NMPA的批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f9c191e301a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702603, encodeId=6d8f1e0260395, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=具备更好的靶选择性，ORR超过88%！复发难治慢性淋巴细胞白血病/小细胞淋巴瘤带来治疗新选择, objectType=article, longId=184372, objectId=a2ac1843e2f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2ac1843e2f7, replyNumber=0, likeNumber=80, createdTime=2020-03-11, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2ac1843e2f7, moduleTitle=具备更好的靶选择性，ORR超过88%！复发难治慢性淋巴细胞白血病/小细胞淋巴瘤带来治疗新选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2ac1843e2f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702607, encodeId=d64c1e026074b, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2020.V4）, objectType=article, longId=185478, objectId=a93e1854e8e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a93e1854e8e8, replyNumber=0, likeNumber=37, createdTime=2020-08-12, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a93e1854e8e8, moduleTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2020.V4）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a93e1854e8e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702593, encodeId=2d661e0259347, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：如何识别外周T细胞淋巴瘤的亚型？, objectType=article, longId=180408, objectId=150d18040810, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=150d18040810, replyNumber=0, likeNumber=69, createdTime=2020-06-09, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=150d18040810, moduleTitle=Blood：如何识别外周T细胞淋巴瘤的亚型？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=150d18040810)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702590, encodeId=b8771e02590fc, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=J Gastroenterology：PD-L1表达在原发性胃和肠弥漫性大B细胞淋巴瘤中的预后影响, objectType=article, longId=179701, objectId=85981e970172, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85981e970172, replyNumber=0, likeNumber=63, createdTime=2019-10-26, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85981e970172, moduleTitle=J Gastroenterology：PD-L1表达在原发性胃和肠弥漫性大B细胞淋巴瘤中的预后影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85981e970172)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702617, encodeId=f6cb1e02617ea, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NEJM：结外自然杀伤T细胞淋巴瘤-病例报道, objectType=article, longId=187577, objectId=0bc218e577de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bc218e577de, replyNumber=0, likeNumber=71, createdTime=2020-09-03, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bc218e577de, moduleTitle=NEJM：结外自然杀伤T细胞淋巴瘤-病例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bc218e577de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702616, encodeId=3ec21e026162f, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=欧洲药品管理局开始审查Kite的自体CAR-T细胞疗法KTE-X19，用于治疗套细胞淋巴瘤, objectType=article, longId=187285, objectId=d73e18e28514, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d73e18e28514, replyNumber=0, likeNumber=99, createdTime=2020-12-09, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d73e18e28514, moduleTitle=欧洲药品管理局开始审查Kite的自体CAR-T细胞疗法KTE-X19，用于治疗套细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d73e18e28514)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702624, encodeId=ddbb1e02624fb, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=细胞接合剂AFM13治疗T细胞淋巴瘤：已获FDA孤儿药认定, objectType=article, longId=191251, objectId=1c771912519e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c771912519e, replyNumber=0, likeNumber=83, createdTime=2020-12-22, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c771912519e, moduleTitle=细胞接合剂AFM13治疗T细胞淋巴瘤：已获FDA孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c771912519e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702578, encodeId=86071e0257800, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：基因组整体分析揭示原发性纵隔大B细胞淋巴瘤的主要致病机制, objectType=article, longId=175631, objectId=b3231e5631fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3231e5631fa, replyNumber=0, likeNumber=54, createdTime=2020-06-16, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3231e5631fa, moduleTitle=Blood：基因组整体分析揭示原发性纵隔大B细胞淋巴瘤的主要致病机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3231e5631fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702614, encodeId=b5671e0261460, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：T细胞淋巴瘤（2020.V1）, objectType=article, longId=186761, objectId=1e1b186e61f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e1b186e61f0, replyNumber=0, likeNumber=33, createdTime=2020-10-09, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e1b186e61f0, moduleTitle=NCCN临床实践指南：T细胞淋巴瘤（2020.V1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e1b186e61f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702606, encodeId=304e1e02606dd, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Lancet Oncol：发现结外自然杀伤T细胞淋巴瘤的新风险位点, objectType=article, longId=185278, objectId=9af81852e823, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9af81852e823, replyNumber=0, likeNumber=56, createdTime=2020-11-11, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9af81852e823, moduleTitle=Lancet Oncol：发现结外自然杀伤T细胞淋巴瘤的新风险位点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9af81852e823)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702587, encodeId=97f81e025877e, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：携带MYC和BCL2/BCL6重排的高级别B细胞淋巴瘤, objectType=article, longId=179636, objectId=788e1e96369b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=788e1e96369b, replyNumber=0, likeNumber=56, createdTime=2019-11-02, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=788e1e96369b, moduleTitle=Blood：携带MYC和BCL2/BCL6重排的高级别B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=788e1e96369b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702588, encodeId=3faf1e0258869, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=儿童ALK 阳性间变性大细胞淋巴瘤诊疗规范(2019年版）, objectType=article, longId=179646, objectId=5e3d1e9646eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e3d1e9646eb, replyNumber=0, likeNumber=23, createdTime=2019-12-01, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e3d1e9646eb, moduleTitle=儿童ALK 阳性间变性大细胞淋巴瘤诊疗规范(2019年版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e3d1e9646eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702582, encodeId=1d281e0258239, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=以肾功能衰竭为首发症状的间变大细胞淋巴瘤1例, objectType=article, longId=178082, objectId=9a541e8082b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a541e8082b9, replyNumber=0, likeNumber=57, createdTime=2020-07-21, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a541e8082b9, moduleTitle=以肾功能衰竭为首发症状的间变大细胞淋巴瘤1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a541e8082b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702600, encodeId=dea01e026004e, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=国内外周T细胞淋巴瘤原创药获批第二个适应症，这次是乳腺癌, objectType=article, longId=183430, objectId=68dd183430c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68dd183430c6, replyNumber=0, likeNumber=134, createdTime=2020-09-13, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68dd183430c6, moduleTitle=国内外周T细胞淋巴瘤原创药获批第二个适应症，这次是乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68dd183430c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细胞淋巴瘤

2020-05-29

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Autolus Therapeutics公布其CD19/CD22双靶CAR-T细胞疗法在大B细胞淋巴瘤中的阳性临床数据

2020-02-10

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Lancet：IPH4102治疗晚期T细胞淋巴瘤的I期临床试验结果

2019-06-29

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

林桐榆教授：复发难治弥漫大B细胞淋巴瘤治疗关键与挑战

2020-02-25

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

JCO：CAR-T用于复发或难治性大B细胞淋巴瘤真实世界数据发布，结果与试验结果一致

2020-11-14

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Verastem的PI3K抑制剂COPIKTRA治疗T细胞淋巴瘤，获得FDA的孤儿药称号

2020-05-03

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

亚盛药业的Bcl-2抑制剂APG-2575用于慢性淋巴细胞白血病或小淋巴细胞淋巴瘤的Ib/II期临床，获得NMPA的批准

2020-04-29

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

具备更好的靶选择性，ORR超过88%！复发难治慢性淋巴细胞白血病/小细胞淋巴瘤带来治疗新选择

2020-03-11

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2020.V4）

2020-08-12

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：如何识别外周T细胞淋巴瘤的亚型？

2020-06-09

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

J Gastroenterology：PD-L1表达在原发性胃和肠弥漫性大B细胞淋巴瘤中的预后影响

2019-10-26

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NEJM：结外自然杀伤T细胞淋巴瘤-病例报道

2020-09-03

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

欧洲药品管理局开始审查Kite的自体CAR-T细胞疗法KTE-X19，用于治疗套细胞淋巴瘤

2020-12-09

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

细胞接合剂AFM13治疗T细胞淋巴瘤：已获FDA孤儿药认定

2020-12-22

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：基因组整体分析揭示原发性纵隔大B细胞淋巴瘤的主要致病机制

2020-06-16

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：T细胞淋巴瘤（2020.V1）

2020-10-09

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Lancet Oncol：发现结外自然杀伤T细胞淋巴瘤的新风险位点

2020-11-11

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：携带MYC和BCL2/BCL6重排的高级别B细胞淋巴瘤

2019-11-02

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

儿童ALK 阳性间变性大细胞淋巴瘤诊疗规范(2019年版）

2019-12-01

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

以肾功能衰竭为首发症状的间变大细胞淋巴瘤1例

2020-07-21

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

国内外周T细胞淋巴瘤原创药获批第二个适应症，这次是乳腺癌

2020-09-13

科室
- - 订阅+
  - 更多科室
工具
服务